Bortenat (Bortezomib) Injection I.P.
Bortenat 3.5mg Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma. It shows its working by stopping or slowing down the growth of cancer cells.
| Brand Name | Bortenat |
| Generic Name | Bortezomib |
| Strength | 3.5mg/Vial |
| Manufacturer | Natco Pharma Ltd. |
Product Overview
Bortenat 3.5mg Injection is an anti-cancer medication. It works by blocking or slowing the breakdown of proteins in cells. As a result, there is an increase in a number of proteins in the cancer cells leading to their death.
Answers to What Matters
Strengthening healthcare delivery through long-standing collaborations built on quality, reliability, and shared purpose.
We supply a comprehensive range of essential, specialty, super specialty, and critical care pharmaceutical products across multiple therapeutic segments.
Yes, we cater to all pin codes in India and ensure delivery through reliable courier services.
We work with hospitals, pharmacies, clinics, healthcare institutions, distributors, and patients through approved supply channels.
Yes. We provide prompt support for urgent and critical medicine needs, subject to availability and compliance requirements.
All products are sourced from authorised manufacturers and handled under strict GDP-compliant storage, documentation, and distribution protocols.
We accept multiple payment modes, including bank transfer, UPI, and other approved digital payment options, as per applicable terms.
Our team typically responds within one business working day.
Yes. Home delivery is available where permitted, ensuring safe and compliant last-stage delivery of medicines.
You can reach us through the enquiry form on our website or contact our team directly for assistance.
Let’s Build a Reliable Pharma Partnership
Reach out to explore how we can support your pharma requirements.
